MDGL
Price
$204.02
Change
+$2.95 (+1.47%)
Updated
Apr 30, 6:59 PM EST
6 days until earnings call
RLAY
Price
$6.52
Change
-$0.07 (-1.06%)
Updated
Apr 30, 6:59 PM EST
One day until earnings call
Ad is loading...

Compare predictions MDGL vs RLAY

Header iconMDGL vs RLAY Comparison
Open Charts MDGL vs RLAYBanner chart's image
Madrigal Pharmaceuticals
Price$204.02
Change+$2.95 (+1.47%)
Volume$208.17K
CapitalizationN/A
Relay Therapeutics
Price$6.52
Change-$0.07 (-1.06%)
Volume$548.76K
CapitalizationN/A
View a ticker or compare two or three
MDGL vs RLAY Comparison Chart

Loading...

MDGLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RLAYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
MDGL vs. RLAY commentary
May 01, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDGL is a Hold and RLAY is a Hold.

COMPARISON
Comparison
May 01, 2024
Stock price -- (MDGL: $204.02 vs. RLAY: $6.52)
Brand notoriety: MDGL and RLAY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDGL: 78% vs. RLAY: 75%
Market capitalization -- MDGL: $4.34B vs. RLAY: $862.82M
MDGL [@Biotechnology] is valued at $4.34B. RLAY’s [@Biotechnology] market capitalization is $862.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $566.59B to $0. The average market capitalization across the [@Biotechnology] industry is $2.58B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDGL’s FA Score shows that 0 FA rating(s) are green whileRLAY’s FA Score has 1 green FA rating(s).

  • MDGL’s FA Score: 0 green, 5 red.
  • RLAY’s FA Score: 1 green, 4 red.
According to our system of comparison, RLAY is a better buy in the long-term than MDGL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDGL’s TA Score shows that 4 TA indicator(s) are bullish while RLAY’s TA Score has 5 bullish TA indicator(s).

  • MDGL’s TA Score: 4 bullish, 5 bearish.
  • RLAY’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, RLAY is a better buy in the short-term than MDGL.

Price Growth

MDGL (@Biotechnology) experienced а -6.58% price change this week, while RLAY (@Biotechnology) price change was +10.51% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.52%. For the same industry, the average monthly price growth was -6.53%, and the average quarterly price growth was +1241.07%.

Reported Earning Dates

MDGL is expected to report earnings on Aug 06, 2024.

RLAY is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Biotechnology (+0.52% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for MDGL with price predictions.
OPEN
A.I.dvisor published
a Summary for RLAY with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
MDGL($4.34B) has a higher market cap than RLAY($863M). MDGL YTD gains are higher at: -11.825 vs. RLAY (-40.781).
MDGLRLAYMDGL / RLAY
Capitalization4.34B863M503%
EBITDAN/AN/A-
Gain YTD-11.825-40.78129%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
MDGL: Fundamental Ratings
MDGL
OUTLOOK RATING
1..100
64
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
60
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MDGLRLAY
RSI
ODDS (%)
Bullish Trend 1 day ago
67%
Bullish Trend 1 day ago
82%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
80%
Bearish Trend 1 day ago
86%
MACD
ODDS (%)
N/A
Bullish Trend 1 day ago
74%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
77%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
78%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 6 days ago
80%
Bearish Trend 9 days ago
89%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
79%
Aroon
ODDS (%)
Bearish Trend 1 day ago
72%
Bearish Trend 1 day ago
83%
View a ticker or compare two or three
Ad is loading...
MDGLDaily Signal changed days agoGain/Loss if shorted
 
Show more...
RLAYDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
ZSC24.400.16
+0.65%
USCF Sustainable Commodity Strategy
DOGG20.21-0.13
-0.65%
FT Cboe Vest DJIA® Dogs 10 Trgt Inc ETF
OALC26.10-0.41
-1.55%
OneAscent Large Cap Core ETF
DGRS46.75-0.97
-2.04%
WisdomTree US SmallCap Qual Div Gr ETF
LIT43.82-1.10
-2.45%
Global X Lithium & Battery Tech ETF

MDGL and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDGL has been loosely correlated with IBRX. These tickers have moved in lockstep 62% of the time. This A.I.-generated data suggests there is some statistical probability that if MDGL jumps, then IBRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDGL
1D Price
Change %
MDGL100%
+1.47%
IBRX - MDGL
62%
Loosely correlated
-11.12%
KA - MDGL
62%
Loosely correlated
-3.60%
VXRT - MDGL
61%
Loosely correlated
+0.20%
VBIV - MDGL
57%
Loosely correlated
+1.24%
ALXO - MDGL
56%
Loosely correlated
+0.53%
More

RLAY and

Correlation & Price change

A.I.dvisor indicates that over the last year, RLAY has been loosely correlated with PRME. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if RLAY jumps, then PRME could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RLAY
1D Price
Change %
RLAY100%
-1.06%
PRME - RLAY
55%
Loosely correlated
+1.23%
NTLA - RLAY
52%
Loosely correlated
-2.64%
XNCR - RLAY
49%
Loosely correlated
-0.62%
ADPT - RLAY
49%
Loosely correlated
-4.73%
BEAM - RLAY
49%
Loosely correlated
-3.76%
More